The Latin America, Middle East and Africa Coated Endotracheal Tube Market would witness market growth of 9.9% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 1,013.4 thousand units, showcasing a growth of 12.1% (2023-2030).
These tubes are made from more biocompatible materials, reducing the risk of adverse reactions. This contributes to coated tubes' overall safety and effectiveness in medical applications. Advances have been made in creating hydrophobic and hydrophilic coatings. These tubes benefit from hydrophobic coatings that repel fluids, reducing the risk of biofilm formation. Hydrophilic coatings enhance lubricity, making intubation smoother and reducing potential complications. Radiopaque materials in these tubes improve their visibility during medical imaging procedures, aiding healthcare professionals in placement and monitoring.
Surgical procedures often involve intubation, creating a demand for advanced endotracheal tubes. The increasing number of surgical interventions contributes to the growth of the market, as these are commonly used in various surgical settings. Certain surgeries demand specialized airway management solutions. These tubes are used in various specialized surgeries, such as cardiovascular, thoracic, and neurosurgical procedures, where precise airway control and reduced trauma are essential.
The UAE has been investing significantly in expanding and enhancing its healthcare infrastructure. The growth of hospitals and medical facilities in the UAE, particularly those equipped with advanced technologies, may contribute to adopting these tubes. The United Arab Emirates is a medical tourism, attracting patients from all over the world. Healthcare facilities catering to global patients prioritize using advanced medical devices in UAE, including these tubes, to maintain high standards of care and safety. Due to these aspects, the market will expand across the LAMEA region in upcoming years.
The Brazil market dominated the LAMEA Coated Endotracheal Tube Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,457.3 Thousands by 2030. The Argentina market is showcasing a CAGR of 10.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 9.6% during (2023 - 2030).
Based on Intubation, the market is segmented into Orotracheal and Nasotracheal. Based on End User, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on Application, the market is segmented into Anesthesia, Emergency Medicine, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sonoma Pharmaceuticals Inc., Becton, Dickinson, and Company, Bactiguard Holding AB (publ), Sharklet Technologies, Inc., Medline Industries, LP, N8 Medical, LLC, Armstrong Medical Ltd (Eakin Healthcare Ltd), Teleflex, Inc. and Venner Medical (Deutschland) GmbH.
These tubes are made from more biocompatible materials, reducing the risk of adverse reactions. This contributes to coated tubes' overall safety and effectiveness in medical applications. Advances have been made in creating hydrophobic and hydrophilic coatings. These tubes benefit from hydrophobic coatings that repel fluids, reducing the risk of biofilm formation. Hydrophilic coatings enhance lubricity, making intubation smoother and reducing potential complications. Radiopaque materials in these tubes improve their visibility during medical imaging procedures, aiding healthcare professionals in placement and monitoring.
Surgical procedures often involve intubation, creating a demand for advanced endotracheal tubes. The increasing number of surgical interventions contributes to the growth of the market, as these are commonly used in various surgical settings. Certain surgeries demand specialized airway management solutions. These tubes are used in various specialized surgeries, such as cardiovascular, thoracic, and neurosurgical procedures, where precise airway control and reduced trauma are essential.
The UAE has been investing significantly in expanding and enhancing its healthcare infrastructure. The growth of hospitals and medical facilities in the UAE, particularly those equipped with advanced technologies, may contribute to adopting these tubes. The United Arab Emirates is a medical tourism, attracting patients from all over the world. Healthcare facilities catering to global patients prioritize using advanced medical devices in UAE, including these tubes, to maintain high standards of care and safety. Due to these aspects, the market will expand across the LAMEA region in upcoming years.
The Brazil market dominated the LAMEA Coated Endotracheal Tube Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,457.3 Thousands by 2030. The Argentina market is showcasing a CAGR of 10.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 9.6% during (2023 - 2030).
Based on Intubation, the market is segmented into Orotracheal and Nasotracheal. Based on End User, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on Application, the market is segmented into Anesthesia, Emergency Medicine, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sonoma Pharmaceuticals Inc., Becton, Dickinson, and Company, Bactiguard Holding AB (publ), Sharklet Technologies, Inc., Medline Industries, LP, N8 Medical, LLC, Armstrong Medical Ltd (Eakin Healthcare Ltd), Teleflex, Inc. and Venner Medical (Deutschland) GmbH.
Scope of the Study
Market Segments Covered in the Report:
By Intubation (Volume, Thousand Units, USD Million, 2019-2030)
- Orotracheal
- Nasotracheal
By End User (Volume, Thousand Units, USD Million, 2019-2030)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
By Application (Volume, Thousand Units, USD Million, 2019-2030)
- Anesthesia
- Emergency Medicine
- Others
By Country (Volume, Thousand Units, USD Million, 2019-2030)
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Sonoma Pharmaceuticals Inc.
- Becton, Dickinson, and Company
- Bactiguard Holding AB (publ)
- Sharklet Technologies, Inc.
- Medline Industries, LP
- N8 Medical, LLC
- Armstrong Medical Ltd (Eakin Healthcare Ltd)
- Teleflex, Inc.
- Venner Medical (Deutschland) GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Coated Endotracheal Tube Market by Intubation
Chapter 5. LAMEA Coated Endotracheal Tube Market by End User
Chapter 6. LAMEA Coated Endotracheal Tube Market by Application
Chapter 7. LAMEA Coated Endotracheal Tube Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Sonoma Pharmaceuticals Inc.
- Becton, Dickinson, and Company
- Bactiguard Holding AB (publ)
- Sharklet Technologies, Inc.
- Medline Industries, LP
- N8 Medical, LLC
- Armstrong Medical Ltd (Eakin Healthcare Ltd)
- Teleflex, Inc.
- Venner Medical (Deutschland) GmbH
Methodology
LOADING...
